Cyril Amarchand Mangaldas acts on cross-border arrangement between Chemours and SRF Ltd

The Chemours Company FC, LLC has entered into a complex cross-border arrangement with SRF Limited for the production of certain fluoropolymers and fluoroelastomers, which Chemours will use to strengthen its global supply chain footprint, bolster operational flexibility, and provide access to capacity for these essential materials.

Cyril Amarchand Mangaldas has advised and assisted Chemours on end-to-end structuring of the transaction and finalisation of the transaction documents. 

The transaction team was led by Soumya Srivastava (Partner), with support from Samaksh Khanna (Associate). 

Kaustav Kundu (Partner) assisted in competition aspects of the transaction.

Chemours is a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM).

SRF Limited is one of India’s diversified, chemical-based multi-business conglomerates. 

By leveraging SRF’s established manufacturing excellence alongside Chemours’ advanced product technology and rigorous quality standards, the collaboration will deliver a reliable supply of high-quality products. The agreements will supplement Chemours’ existing global operations, allowing Chemours to efficiently bring supply flexibility while requiring no upfront capital investment.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.